ARCK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ARCK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.
Arbor Rapha Capital Bioholdings I's Net Income Including Noncontrolling Interests for the three months ended in Sep. 2022 was $0.35 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2022 was $-0.19 Mil.
The historical data trend for Arbor Rapha Capital Bioholdings I's Net Income Including Noncontrolling Interests can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arbor Rapha Capital Bioholdings I Annual Data | |||
Trend | Dec21 | ||
Net Income Including Noncontrolling Interests | - |
Arbor Rapha Capital Bioholdings I Quarterly Data | ||||||||
Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | ||
Net Income Including Noncontrolling Interests | Get a 7-Day Free Trial | - | - | -0.45 | -0.09 | 0.35 |
Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.
Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.19 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.
Ralph Mack | director | 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553 |
Kevin M. Slawin | director, officer: Chief Strategy Officer | C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030 |
Ivan Kaufman | director, 10 percent owner, officer: Chief Executive Officer | |
Arbor Commercial Mortgage Llc | director, 10 percent owner, officer: Chief Executive Officer | 333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553 |
Paul Elenio | officer: Chief Financial Officer | C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553 |
John Natalone | officer: Treasurer | C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553 |
William P Connolly | officer: Secretary & Vice President | C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553 |
Cyrus D. Walker | director | C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139 |
Arbor Rapha Capital Llc | director, 10 percent owner, officer: Chief Executive Officer | 333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553 |
Avery Modlin | director | C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553 |
From GuruFocus
By PRNewswire PRNewswire • 11-02-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.